Bromelain based enzymatic debridement in burn patients, its outcome, advantages and disadvantages
DOI:
https://doi.org/10.18203/2349-2902.isj20243238Keywords:
Bromelain, Deep burns, Enzymatic debridement, Infection rate, Total burn surface area, Wound healingAbstract
The aim of this study is to evaluate the outcomes, advantages, and disadvantages of bromelain-based enzymatic debridement in the management of burn wounds. Ours is a study in which we have selected 10 patients with deep dermal and full thickness burns admitted in SMS hospital, Jaipur. These patients underwent bromelain based enzymatic debridement applied as per the manufactures protocol. The patients were then observed for bromelain’s efficacy in debridement, wound healing, pain, duration of hospital stay, superadded bacteraemia and cosmetic outcome. Complete removal of burn eschar was observed in 9 out of 10 patients. Bromelain-based enzymatic debridement effectively removed necrotic tissue within a shorter timeframe compared to traditional methods. Patients treated with bromelain-based enzymatic debridement showed significantly faster wound healing, reduced infection rates, and lower pain levels during debridement. Improved cosmetic outcomes, such as reduced scarring and better skin texture, were also observed. Bromelain-based enzymatic debridement offers notable advantages in burn care, including expedited healing and enhanced patient comfort. Despite these benefits, the treatment's higher cost and the risk of allergic reactions are important considerations. The limited availability of bromelain-based products also poses a challenge. These factors suggest that while bromelain is a promising alternative, its use should be carefully evaluated based on individual patient needs and resource availability.
References
Schulz A, Fuchs PC, Hans N, Opländer C, Valdez LB, Schiefer JL. Inhibition of bromelain activity during enzymatic debridement of burn wounds pretreated with frequently used products. J Burn Care Res. 2018;20;39(3):413‐22.
Levenson SM, Kan D, Gruber C. Chemical debridement of burns. Ann Surg. 1974;180(4):670‐704.
Silverstein P, Ruzicka FJ, Helmkamp GM, Lincoln RA, Mason AD. In vitro evaluation of enzymatic debridement of burns wound eschar. Surgery. 1973;73(1):15‐22.
Levine N, Seifter E, Connerton C, Levenson SM. Debridement of experimental skin burns of pigs with bromelain, a pineapple‐stem enzyme. Plast Reconstr Surg. 1973;52(4):413‐24.
Muhammad ZA, Ahmad T. Therapeutic uses of pineapple‐extracted bromelain in surgical care—a review. J Pak Med Assoc. 2017;67(1):121‐5.
Hasannasab M, Nourmohammadi J, Dehghan MM, Ghaee A. Immobilization of bromelain and ZnO nanoparticles on silk fibroin nanofibers as an antibacterial and anti‐inflammatory burn dressing. Int J Pharm. 2021;610:121227.
Orsini RA. Plastic surgery educational foundation technology assessment committee. Bromelain Plast Reconstr Surg. 2006;118(7):1640‐4.
Sharaf A, Muthayya P. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®. Burns. 2022;48(7):1618-25.
Korting HC, Schöllmann C. Management of minor acute cutaneous wounds: importance of wound healing in a moist environment. J European Acad Dermatol Venereol. 2020;26(8);373-82.
Smith M, Brightman AO. Enzymatic debridement in wound management: a systematic review. Wound Repair and Regeneration. 2020;10(2);95-101.
Singer AJ, McClain SA. The effects of a moist, enzyme-based debridement on human dermal fibroblasts. J Burn Care Rehabil. 2003;24(5);268-72.